Cargando…

Retrospective analysis of the impact of platinum dose reduction and chemotherapy delays on the outcomes of stage III ovarian cancer patients

BACKGROUND: Ovarian cancer is a common gynaecological malignancy still remaining a challenge to treat. The objective of this study was to evaluate the impact of platinum dose reduction and chemotherapy delays on progression free survival and overall survival in patients with stage III ovarian cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liutkauskiene, Sigita, Janciauskiene, Rasa, Jureniene, Kristina, Grizas, Saulius, Malonyte, Rasa, Juozaityte, Elona
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359455/ https://www.ncbi.nlm.nih.gov/pubmed/25879527 http://dx.doi.org/10.1186/s12885-015-1104-5

Ejemplares similares

Retrospective analysis of the impact of anthracycline dose reduction and chemotherapy delays on the outcomes of early breast cancer molecular subtypes
por: Liutkauskiene, Sigita, et al.
Publicado: (2018)

Sequential treatment of metastatic renal cell carcinoma patients after first-line vascular endothelial growth factor targeted therapy in a real-world setting: epidemiologic, noninterventional, retrospective–prospective cohort multicentre study
por: Cesas, Alvydas, et al.
Publicado: (2023)

Systemic Optimization of Gene Electrotransfer Protocol Using Hard-to-Transfect UT-7 Cell Line as a Model
por: Vadeikienė, Roberta, et al.
Publicado: (2022)

Pathomorphological Manifestations and the Course of the Cervical Cancer Disease Determined by Variations in the TLR4 Gene
por: Žilienė, Eglė, et al.
Publicado: (2023)

siRNA Knockdown of REDD1 Facilitates Aspirin-Mediated Dephosphorylation of mTORC1 Target 4E-BP1 in MDA-MB-468 Human Breast Cancer Cell Line
por: Savukaitytė, Aistė, et al.
Publicado: (2021)

DDIT4 Downregulation by siRNA Approach Increases the Activity of Proteins Regulating Fatty Acid Metabolism upon Aspirin Treatment in Human Breast Cancer Cells
por: Savukaitytė, Aistė, et al.
Publicado: (2023)

Investigation of prognostic value of polymorphisms within estrogen metabolizing genes in Lithuanian breast cancer patients
por: Savukaitytė, Aistė, et al.
Publicado: (2015)

Corticosteroid-Responsive Pulmonary Toxicity Associated with Fludarabine Monophosphate: A Case Report
por: Rudzianskiene, Milda, et al.
Publicado: (2012)

The prognostic value of IL10 and TNF alpha functional polymorphisms in premenopausal early-stage breast cancer patients
por: Korobeinikova, Erika, et al.
Publicado: (2015)

Association of angiogenesis and inflammation-related gene functional polymorphisms with early-stage breast cancer prognosis
por: Korobeinikova, Erika, et al.
Publicado: (2020)

Associations of MDM2 and MDM4 Polymorphisms with Early-Stage Breast Cancer
por: Bartnykaitė, Agnė, et al.
Publicado: (2021)

Mitochondria-related TFAM gene variants and their effects on patients with cervical cancer
por: Golubickaite, Ieva, et al.
Publicado: (2021)

The Investigation of Associations between TP53 rs1042522, BBC3 rs2032809, CCND1 rs9344, EGFR rs2227983 Polymorphisms and Breast Cancer Phenotype and Prognosis
por: Bekampytė, Justina, et al.
Publicado: (2021)

POLG Gene Variants in Cervical Cancer Patients and Their Associations with Clinical and Pathomorphological Tumor Characteristics
por: Golubickaite, Ieva, et al.
Publicado: (2021)

TIRAP Rs8177376, Rs611953, Rs3802814, and Rs8177374 Polymorphisms and Their Association with Cervical Cancer Phenotype and Prognosis
por: Bekampytė, Justina, et al.
Publicado: (2022)

Gene methylation profile of gastric cancerous tissue according to tumor site in the stomach
por: Kupcinskaite-Noreikiene, Rita, et al.
Publicado: (2016)

Duffy and Kidd Genotyping Facilitates Pretransfusion Testing in Patients Undergoing Long-Term Transfusion Therapy
por: Remeikiene, Diana, et al.
Publicado: (2014)

The Role of Matrix Metalloproteinase Single-Nucleotide Polymorphisms in the Clinicopathological Properties of Breast Cancer
por: Bartnykaitė, Agnė, et al.
Publicado: (2022)

Mitochondria-Related TFAM and POLG Gene Variants and Associations with Tumor Characteristics and Patient Survival in Head and Neck Cancer
por: Golubickaite, Ieva, et al.
Publicado: (2023)

Sarcocystis spp. Macrocysts Infection in Wildfowl Species in Eastern Baltic Region: Trends in Prevalence in 2011–2022
por: Prakas, Petras, et al.
Publicado: (2023)

Comparison of adjuvant and neoadjuvant chemotherapy in the management of advanced ovarian cancer: a retrospective study of 574 patients
por: Inciura, Arturas, et al.
Publicado: (2006)

Preoperative conventional chemoradiotherapy versus short-course radiotherapy with delayed surgery for rectal cancer: results of a randomized controlled trial
por: Latkauskas, Tadas, et al.
Publicado: (2016)

Multidisciplinary approach to rare primary cardiac sarcoma: a case report and review
por: Vaitiekiene, Audrone, et al.
Publicado: (2019)

Analysis of intracorporeal knotting with invaginating suture versus endoloops in appendiceal stump closure
por: Kiudelis, Mindaugas, et al.
Publicado: (2012)

Chemotherapy vs tamoxifen in platinum-resistant ovarian cancer: a phase III, randomised, multicentre trial (Ovaresist)
por: Lindemann, Kristina, et al.
Publicado: (2017)

Weekly platinum chemotherapy for recurrent ovarian cancer
por: Clamp, A, et al.
Publicado: (2002)

Significance of platinum distribution to predict platinum resistance in ovarian cancer after platinum treatment in neoadjuvant chemotherapy
por: Uno, Kaname, et al.
Publicado: (2022)

Bevacizumab in combination with chemotherapy in platinum-sensitive ovarian cancer
por: Della Pepa, Chiara, et al.
Publicado: (2014)

Ovarian cancer resistance to PARPi and platinum-containing chemotherapy
por: Summey, Rebekah, et al.
Publicado: (2022)

Delay of the Blink Reflex in Patients Receiving Platinum-Analogue Chemotherapy
por: Park, Kang Young, et al.
Publicado: (2016)

Risk Factors for Delayed Neurocognitive Recovery According to Brain Biomarkers and Cerebral Blood Flow Velocity
por: Bukauskienė, Rasa, et al.
Publicado: (2020)

Bevacizumab in combination with chemotherapy in platinum-sensitive ovarian cancer [Corrigendum]
Publicado: (2014)

Molecular mechanisms of platinum-based chemotherapy resistance in ovarian cancer
por: Yang, Ling, et al.
Publicado: (2022)

Phase I trial of ribociclib with platinum chemotherapy in ovarian cancer
por: Coffman, Lan G., et al.
Publicado: (2022)

Heterogeneous effects of cytotoxic chemotherapies for platinum-resistant ovarian cancer
por: Nara, Katsuhiko, et al.
Publicado: (2023)

The efficacy and safety profile of 2-weekly dosing of bevacizumab-containing chemotherapy for platinum-resistant recurrent ovarian cancer
por: Sekine, Masayuki, et al.
Publicado: (2021)

Trabectedin plus pegylated liposomal doxorubicin in relapsed ovarian cancer delays third-line chemotherapy and prolongs the platinum-free interval
por: Kaye, S. B., et al.
Publicado: (2011)

The recognition domain of the methyl-specific endonuclease McrBC flips out 5-methylcytosine
por: Sukackaite, Rasa, et al.
Publicado: (2012)

Dietary Ruminant Enteric Methane Mitigation Strategies: Current Findings, Potential Risks and Applicability
por: Lileikis, Tomas, et al.
Publicado: (2023)

Molecular basis of chemosensitivity of platinum pre-treated ovarian cancer to chemotherapy
por: Glaysher, S, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_9mst763hajlengf4akihm81io6